Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:ALDR
Delisted

Alder BioPharmaceuticals Stock Price (Quote)

$18.88
+0 (+0%)
At Close: Apr 15, 2020

Range Low Price High Price Comment
30 days $18.88 $18.88 Wednesday, 15th Apr 2020 ALDR stock ended at $18.88. During the day the stock fluctuated 0% from a day low at $18.88 to a day high of $18.88.
90 days $18.88 $18.88
52 weeks $8.39 $19.12

Historical Alder BioPharmaceuticals prices

Date Open High Low Close Volume
Nov 28, 2016 $26.55 $26.70 $23.60 $23.65 1 396 169
Nov 25, 2016 $25.70 $26.87 $25.20 $26.80 297 293
Nov 23, 2016 $24.40 $25.88 $23.85 $25.60 827 243
Nov 22, 2016 $26.60 $27.40 $24.83 $25.30 888 981
Nov 21, 2016 $28.60 $28.60 $25.55 $26.45 1 098 954
Nov 18, 2016 $29.30 $29.30 $27.30 $28.75 1 020 092
Nov 17, 2016 $29.85 $29.95 $27.75 $29.30 992 749
Nov 16, 2016 $32.75 $32.80 $29.50 $29.57 780 565
Nov 15, 2016 $33.65 $34.30 $31.80 $32.95 756 649
Nov 14, 2016 $32.50 $34.30 $31.80 $34.15 670 331
Nov 11, 2016 $31.50 $32.35 $30.50 $32.15 687 903
Nov 10, 2016 $29.90 $31.35 $29.40 $30.35 978 333
Nov 09, 2016 $28.80 $30.60 $27.65 $29.50 1 853 212
Nov 08, 2016 $26.00 $26.00 $26.00 $26.00 414 004
Nov 07, 2016 $26.10 $26.10 $26.10 $26.10 909 800
Nov 04, 2016 $24.15 $24.15 $24.15 $24.15 722 900
Nov 03, 2016 $22.40 $22.40 $22.40 $22.40 649 700
Nov 02, 2016 $23.80 $23.80 $23.80 $23.80 602 800
Nov 01, 2016 $24.50 $24.50 $24.50 $24.50 601 200
Oct 31, 2016 $24.25 $24.25 $24.25 $24.25 766 200
Oct 28, 2016 $24.80 $24.80 $24.80 $24.80 1 895 200
Oct 27, 2016 $26.80 $26.80 $26.80 $26.80 568 500
Oct 26, 2016 $27.45 $27.45 $27.45 $27.45 415 400
Oct 25, 2016 $28.15 $28.15 $28.15 $28.15 418 800
Oct 24, 2016 $29.55 $29.55 $29.55 $29.55 243 600
Click to get the best stock tips daily for free!

About Alder BioPharmaceuticals

Alder BioPharmaceuticals Alder BioPharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes therapeutic antibodies in the United States and Australia. The company’s lead product candidate ALD403, an antibody, which is in Phase II clinical trial to target calcitonin gene-related peptide for the prevention of migraine. It also develops ALD1613, which is in preclinical stage to treat patients with congenital adrenal hyperpla... ALDR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT